Magali Madeleine Simone Motte

This inventor holds 25 USPTO granted patents and 12 published patent applications, plus 15 CIPO patents and 17 EPO patents, primarily in Antibacterial Compounds. Top assignees: Janssen Sciences Ireland Uc, Janssen Pharmaceutica Nv, Janssen Sciences Ireland Unlimited Company. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Magali Madeleine Simone Motte. Retrieved from https://idiyas.com/inventor/magali-madeleine-simone-motte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 12)

% Patents Active = 88.0

CIPO Patents = 15 (Patent Applications = 6)

EPO Patents = 17 (Patent Applications = 18)

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 37(Granted Patents)

Location History:

Heudebouville, FR (2011 - 2012)
Val de Reuil Cedex, FR (2014 - 2015)
Val de Reuil, FR (2017)
Louviers, FR (2014 - 2024)

Company Filing History:

15 out of 111

Janssen Sciences Ireland Uc

patents

5 out of 2,101

Janssen Pharmaceutica Nv

patents

3 out of 64

Janssen Sciences Ireland Unlimited Company

Years Active: 2011-2024

Loading Chart...

Areas of Expertise:

Antibacterial Compounds

Cyclopenta Derivatives

Quinoline Analogs

Piperidinyl Substitutes

Homopiperidinyl

Functionalized Pentanoic Acids

RSV Antiviral Compounds

Infection Treatment

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11866419 - Antibacterial compounds (2024-01-09),

2. 11180472 - Antibacterial compounds (2021-11-23),

3. 10526338 - Functionalized pentanoic acids for use influenza viral infections (2020-01-07),

4. 10526331 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2020-01-07),

5. 10501463 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2019-12-10),

6. 10364232 - Antibacterial compounds (2019-07-30),

7. 10155759 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2018-12-18),

8. 10150761 - Substituted pyridine-piperazinyl analogues as RSV antiviral compounds (2018-12-11),

9. 9951032 - Antibacterial compounds (2018-04-24),

10. 9884864 - Antibacterial cyclopenta[C]pyrrole substituted 3,4-Dihydro-1H-[1,8]naphthyridinones (2018-02-06),

11. 9758497 - Antibacterial compounds (2017-09-12),

12. 9617262 - Antibacterial cyclopental[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2017-04-11),

13. 9617244 - Antibacterial quinoline derivatives (2017-04-11),

14. 9598407 - Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2017-03-21),

15. 9428474 - Antibacterial compounds (2016-08-30),

Title: Magali Madeleine Simone Motte – Pioneering Antibacterial Innovations in Louviers, France

Introduction

Magali Madeleine Simone Motte is a distinguished inventor based in Louviers, France. With an impressive portfolio of 25 patents, he has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial compounds.

Latest Patents

Motte's recent inventions focus on antibacterial compounds that hold promise for treating tuberculosis. The present invention relates to various compounds, wherein the integers are defined in the description, illustrating their potential as effective medicaments. These innovative compounds highlight Motte's commitment to addressing serious health challenges with novel solutions.

Career Highlights

Throughout his career, Magali Madeleine Simone Motte has worked with renowned companies such as Janssen Sciences Ireland UC and Janssen Pharmaceutica NV. His work at these institutions underscores his dedication to advancing pharmaceutical research and developing groundbreaking treatments.

Collaborations

Motte has collaborated with several notable professionals in his field. Among his colleagues are Anil Koul and Wendy Mia Albert Balemans, both of whom share his passion for innovation and have contributed to significant advancements in the pharmaceutical industry.

Conclusion

In conclusion, Magali Madeleine Simone Motte's contributions to antibacterial research and innovation reflect his commitment to improving public health. With 25 patents and ongoing research, his work continues to inspire future developments in the medical field. His collaborations and professional journey exemplify the spirit of innovation that drives progress in science and medicine.

Profile summary based on public USPTO records.